PRPF38B | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	37 studies	37% ± 10%	Explore
B cell	33 studies	31% ± 10%	Explore
CD8-positive, alpha-beta T cell	33 studies	33% ± 9%	Explore
T cell	32 studies	31% ± 9%	Explore
CD4-positive, alpha-beta T cell	32 studies	32% ± 10%	Explore
endothelial cell	30 studies	27% ± 10%	Explore
macrophage	28 studies	32% ± 9%	Explore
fibroblast	25 studies	26% ± 9%	Explore
regulatory T cell	24 studies	34% ± 8%	Explore
conventional dendritic cell	22 studies	30% ± 15%	Explore
classical monocyte	21 studies	24% ± 11%	Explore
pericyte	20 studies	26% ± 8%	Explore
smooth muscle cell	19 studies	24% ± 6%	Explore
memory B cell	19 studies	29% ± 7%	Explore
naive B cell	19 studies	30% ± 7%	Explore
non-classical monocyte	19 studies	26% ± 11%	Explore
mature NK T cell	19 studies	34% ± 9%	Explore
plasmacytoid dendritic cell	18 studies	35% ± 10%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	17 studies	31% ± 10%	Explore
gamma-delta T cell	17 studies	38% ± 12%	Explore
dendritic cell	16 studies	28% ± 17%	Explore
monocyte	16 studies	26% ± 7%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	37% ± 12%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	36% ± 11%	Explore
mast cell	14 studies	23% ± 6%	Explore
endothelial cell of lymphatic vessel	13 studies	22% ± 6%	Explore
basal cell	13 studies	28% ± 11%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	34% ± 9%	Explore
mucosal invariant T cell	13 studies	31% ± 5%	Explore
CD4-positive, alpha-beta memory T cell	12 studies	35% ± 11%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	37% ± 9%	Explore
microglial cell	12 studies	33% ± 11%	Explore
endothelial cell of vascular tree	12 studies	22% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell	11 studies	35% ± 13%	Explore
connective tissue cell	11 studies	26% ± 6%	Explore
epithelial cell	11 studies	37% ± 19%	Explore
plasma cell	10 studies	25% ± 12%	Explore
myofibroblast cell	10 studies	25% ± 9%	Explore
leukocyte	9 studies	35% ± 10%	Explore
myeloid cell	9 studies	29% ± 13%	Explore
type I pneumocyte	8 studies	22% ± 6%	Explore
endothelial cell of artery	8 studies	22% ± 5%	Explore
goblet cell	8 studies	25% ± 10%	Explore
secretory cell	7 studies	25% ± 7%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	32% ± 7%	Explore
capillary endothelial cell	7 studies	26% ± 5%	Explore
abnormal cell	7 studies	24% ± 6%	Explore
vein endothelial cell	7 studies	22% ± 5%	Explore
ciliated cell	7 studies	29% ± 11%	Explore
T follicular helper cell	7 studies	38% ± 8%	Explore
oligodendrocyte	7 studies	25% ± 6%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	33% ± 11%	Explore
mononuclear phagocyte	6 studies	32% ± 18%	Explore
glutamatergic neuron	6 studies	32% ± 15%	Explore
progenitor cell	6 studies	22% ± 5%	Explore
lymphocyte	6 studies	34% ± 13%	Explore
precursor B cell	6 studies	38% ± 11%	Explore
innate lymphoid cell	6 studies	34% ± 10%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	38% ± 14%	Explore
oligodendrocyte precursor cell	6 studies	26% ± 3%	Explore
exhausted T cell	5 studies	40% ± 10%	Explore
pro-B cell	5 studies	41% ± 6%	Explore
immature B cell	5 studies	38% ± 6%	Explore
type II pneumocyte	5 studies	24% ± 10%	Explore
astrocyte	5 studies	30% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	28% ± 8%	Explore
hematopoietic precursor cell	4 studies	42% ± 17%	Explore
mesothelial cell	4 studies	17% ± 1%	Explore
hematopoietic stem cell	4 studies	24% ± 6%	Explore
CD4-positive helper T cell	4 studies	37% ± 13%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	23% ± 4%	Explore
adipocyte	4 studies	17% ± 3%	Explore
neuron	4 studies	29% ± 13%	Explore
brush cell	4 studies	22% ± 6%	Explore
enteroendocrine cell	4 studies	27% ± 13%	Explore
alveolar macrophage	4 studies	23% ± 6%	Explore
transit amplifying cell	4 studies	23% ± 7%	Explore
T-helper 17 cell	4 studies	34% ± 9%	Explore
interneuron	4 studies	32% ± 14%	Explore
double negative thymocyte	4 studies	42% ± 16%	Explore
plasmablast	3 studies	49% ± 21%	Explore
neural crest cell	3 studies	30% ± 5%	Explore
retinal bipolar neuron	3 studies	37% ± 11%	Explore
club cell	3 studies	25% ± 10%	Explore
retinal cone cell	3 studies	35% ± 7%	Explore
tissue-resident macrophage	3 studies	27% ± 8%	Explore
Mueller cell	3 studies	20% ± 5%	Explore
rod bipolar cell	3 studies	41% ± 6%	Explore
respiratory goblet cell	3 studies	28% ± 8%	Explore
germinal center B cell	3 studies	25% ± 5%	Explore
GABAergic neuron	3 studies	37% ± 2%	Explore
pancreatic ductal cell	3 studies	41% ± 22%	Explore
group 3 innate lymphoid cell	3 studies	42% ± 9%	Explore
granule cell	3 studies	20% ± 4%	Explore
hepatocyte	3 studies	39% ± 16%	Explore
T-helper 1 cell	3 studies	33% ± 10%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	32% ± 1%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	28% ± 2%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	16 studies	25% ± 8%	Explore
peripheral blood	16 studies	32% ± 12%	Explore
intestine	9 studies	26% ± 11%	Explore
brain	8 studies	34% ± 10%	Explore
kidney	5 studies	27% ± 7%	Explore
eye	5 studies	25% ± 5%	Explore
lymph node	5 studies	30% ± 7%	Explore
liver	5 studies	36% ± 14%	Explore
uterus	4 studies	29% ± 12%	Explore
breast	4 studies	25% ± 6%	Explore
adipose	4 studies	20% ± 3%	Explore
pancreas	3 studies	36% ± 19%	Explore
bone marrow	3 studies	27% ± 8%	Explore
prostate	3 studies	24% ± 7%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
bladder	100%	4780.67	21 / 21	100%	29.20	504 / 504
lung	100%	6084.27	578 / 578	100%	28.06	1155 / 1155
ovary	100%	4978.91	180 / 180	100%	24.68	430 / 430
prostate	100%	5351.13	245 / 245	100%	28.64	502 / 502
uterus	100%	5250.71	170 / 170	100%	34.41	459 / 459
esophagus	100%	4496.43	1444 / 1445	100%	37.93	183 / 183
breast	100%	5744.23	459 / 459	100%	31.54	1116 / 1118
intestine	100%	5936.09	966 / 966	100%	32.25	526 / 527
brain	100%	4435.50	2635 / 2642	100%	28.66	705 / 705
stomach	100%	4288.82	359 / 359	100%	31.19	285 / 286
thymus	100%	6428.40	653 / 653	100%	29.04	602 / 605
pancreas	100%	4156.08	328 / 328	99%	28.72	176 / 178
kidney	100%	3984.44	89 / 89	97%	22.74	876 / 901
adrenal gland	100%	4445.19	258 / 258	97%	14.23	222 / 230
skin	100%	5172.07	1809 / 1809	96%	27.66	451 / 472
liver	100%	2856.83	226 / 226	92%	13.76	373 / 406
adipose	100%	5317.27	1204 / 1204	0%	0	0 / 0
blood vessel	100%	4245.84	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	31.98	29 / 29
spleen	100%	9740.56	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	29.12	45 / 45
ureter	0%	0	0 / 0	100%	12.89	1 / 1
muscle	100%	2927.47	800 / 803	0%	0	0 / 0
heart	98%	2529.94	846 / 861	0%	0	0 / 0
peripheral blood	92%	3549.63	852 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	79%	12.46	63 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

GO_0008380	Biological process	RNA splicing
GO_0006397	Biological process	mRNA processing
GO_0071011	Cellular component	precatalytic spliceosome
GO_0003723	Molecular function	RNA binding

Gene name	PRPF38B
Protein name	Pre-mRNA-splicing factor 38B Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)
Synonyms	DKFZp434O1172 hCG_39919
Description	FUNCTION: May be required for pre-mRNA splicing. . FUNCTION: May be required for pre-mRNA splicing. . FUNCTION: May be required for pre-mRNA splicing. .
Accessions	Q69YH0 ENST00000370022.9 [Q5VTL8-2] ENST00000370021.1 Q5VTL8 ENST00000370025.9 [Q5VTL8-1] A0A0A0MRN0

PRPF38B report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review